ZOLL Executive and Leadership Team

Eric Knudsen, the Chief Executive Officer at ZOLL, directs the overarching strategic vision for the organization. Overseeing global operations across North America, Europe, and Asia, the Chief Executive Officer ensures the development of innovative medical devices for cardiopulmonary and respiratory conditions. This leadership role involves aligning corporate objectives with the evolving needs of healthcare providers worldwide. By prioritizing research and development, Knudsen drives the creation of advanced life support equipment and monitoring systems. The Chief Executive Officer maintains constant communication with the Board to ensure long-term growth and market stability. Through rigorous oversight of product innovation, Eric Knudsen secures the company's position as a leader in critical care technology. This executive focus on operational excellence supports the mission of improving patient outcomes in high-stakes medical environments while expanding the global footprint of the organization.

Walter Hall, the Vice President Finance and Admin and Chief Financial Officer at ZOLL, manages the fiscal health and administrative infrastructure of the organization. Overseeing global financial planning and analysis, the Vice President Finance and Admin and Chief Financial Officer drives capital allocation strategies to support medical technology innovation. This role involves maintaining rigorous compliance standards and optimizing administrative processes to enhance operational efficiency. By analyzing market trends and revenue streams, Hall ensures the financial stability required for long-term investment in cardiopulmonary research. The Vice President Finance and Admin and Chief Financial Officer coordinates with executive leadership to evaluate the economic impact of new product launches. Walter Hall directs the financial reporting functions to provide transparency for stakeholders. Through the management of corporate assets and administrative resources, the Vice President Finance and Admin and Chief Financial Officer secures the necessary funding to sustain the company's global operations and commitment to patient care.

Sean Rollman, the Chief Financial Officer & Zoll Site Leader (Pittsburgh) & Vice President, Operations & Services at ZOLL, manages the financial and operational performance of the Pittsburgh site. Overseeing the integration of services with financial planning, the Chief Financial Officer & Zoll Site Leader (Pittsburgh) & Vice President, Operations & Services drives the efficiency of service delivery models for medical devices. This role involves balancing budgetary constraints with the need for high-quality operational support. By leading the Pittsburgh team, Rollman ensures that service operations align with the broader corporate strategy for cardiopulmonary care. The Chief Financial Officer & Zoll Site Leader (Pittsburgh) & Vice President, Operations & Services monitors service metrics to improve customer satisfaction and equipment reliability. Sean Rollman coordinates with other C-suite leaders to optimize the service revenue stream. Through the management of site-specific operations, the Chief Financial Officer & Zoll Site Leader (Pittsburgh) & Vice President, Operations & Services supports the company's commitment to providing comprehensive care solutions.

Osnat Gat, the Chief Operating Officer (Israel) at ZOLL, directs the manufacturing and supply chain logistics within the regional operations. Overseeing the production of critical care devices, the Chief Operating Officer (Israel) drives quality control initiatives to ensure compliance with international medical standards. This role involves managing the daily operations of manufacturing facilities to optimize output and reduce lead times. By streamlining the assembly process for defibrillators and monitoring systems, Gat ensures that healthcare providers receive essential equipment without delay. The Chief Operating Officer (Israel) collaborates with global procurement teams to secure high-quality components for the product portfolio. Osnat Gat maintains a focus on continuous improvement to enhance the efficiency of the regional production cycle. Through the implementation of lean manufacturing principles, the Chief Operating Officer (Israel) supports the company's ability to scale operations and meet the growing global demand for advanced life support technology.

Suzy Drees, the President at ZOLL, directs the strategic execution of business initiatives across the organization. Overseeing the alignment of departmental goals with the company's mission, the President drives the expansion of market reach for medical technology solutions. This role involves fostering collaboration between product development, sales, and service teams to ensure a cohesive approach to patient care. By evaluating market opportunities, Drees identifies areas for growth in the cardiopulmonary and respiratory sectors. The President maintains a focus on organizational culture and leadership development to sustain high performance. Suzy Drees coordinates with the executive team to implement policies that enhance operational agility. Through the oversight of key business functions, the President ensures that the company remains responsive to the needs of healthcare providers. This leadership role supports the long-term vision of delivering innovative diagnostic and treatment systems that improve patient outcomes in critical care situations globally.

Michael Blastick, the President, Zoll Cardiac Management Solutions at ZOLL, directs the specialized business unit focused on cardiac monitoring and management. Overseeing the development and commercialization of cardiac-specific technologies, the President, Zoll Cardiac Management Solutions drives the adoption of these tools by healthcare providers. This role involves tailoring product strategies to address the unique requirements of cardiac care environments. By analyzing clinical data and market trends, Blastick ensures that the cardiac management portfolio remains at the cutting edge of medical innovation. The President, Zoll Cardiac Management Solutions coordinates with sales and marketing teams to expand the presence of these solutions in global markets. Michael Blastick maintains a focus on improving patient outcomes through the effective use of monitoring systems. Through the strategic management of this business unit, the President, Zoll Cardiac Management Solutions contributes to the company's overall success in the critical care sector.

Elijah White, the Executive Officer President, ZOLL Acute Care Technology at ZOLL, directs the innovation and market strategy for acute care medical devices. Overseeing the development of advanced life support equipment, the Executive Officer President, ZOLL Acute Care Technology drives the integration of new technologies into hospital and emergency care settings. This role involves managing the product roadmap to ensure that acute care solutions meet the rigorous demands of critical care professionals. By collaborating with clinical experts, White ensures that all devices provide accurate and reliable data for patient treatment. The Executive Officer President, ZOLL Acute Care Technology monitors the competitive landscape to maintain the company's leadership in acute care. Elijah White coordinates with global operations to ensure the timely delivery of these essential technologies. Through the strategic focus on acute care, the Executive Officer President, ZOLL Acute Care Technology supports the company's mission to improve patient outcomes in high-acuity medical situations.

Koby Sheffy, the Chief Technology Officer at ZOLL, architects the technical roadmap for next-generation medical devices. Focusing on the engineering of automated external defibrillators, the Chief Technology Officer drives the integration of software solutions into existing hardware platforms. This role involves managing complex research initiatives to enhance diagnostic accuracy in critical care settings. By collaborating with engineering teams, Sheffy ensures that all technological advancements meet stringent global regulatory standards. The Chief Technology Officer monitors emerging trends in medical electronics to maintain a competitive edge in the healthcare sector. Koby Sheffy directly influences the product lifecycle from initial design to final deployment. Through the implementation of scalable technical frameworks, the Chief Technology Officer optimizes the performance of monitoring systems. This strategic focus on innovation ensures that the company remains at the forefront of cardiopulmonary treatment technology while delivering reliable tools to healthcare providers.

Uriel Weinstein, the General Manager and Chief Technology Officer at ZOLL, manages the intersection of technical development and regional business execution. Overseeing the implementation of advanced respiratory technology, the General Manager and Chief Technology Officer drives operational efficiency within the product development pipeline. This role involves coordinating cross-functional teams to accelerate the delivery of life-saving equipment to global markets. By bridging the gap between engineering innovation and commercial application, Weinstein ensures that technical solutions address specific clinical challenges. The General Manager and Chief Technology Officer monitors market feedback to refine product features and improve user experience. Uriel Weinstein maintains a focus on scaling production capabilities to meet the rising demand for critical care devices. Through the alignment of technical resources with business goals, the General Manager and Chief Technology Officer supports the company's mission to provide high-quality medical solutions to healthcare providers across diverse international regions.